Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             427 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Ability of ultrasonography to detect cystic fibrosis in utero Scotet, V.
 2009
 8 S2 p. S16-
1 p.
 artikel
2 Accumulation of NKT cells in tissues of cystic fibrosis mice Siegmann, N.
 2009
 8 S2 p. S54-
1 p.
 artikel
3 Accuracy of a self-administered questionnaire to estimated maximal exercise capacity in CF patients Leroy, S.
 2009
 8 S2 p. S58-
1 p.
 artikel
4 Activity of liposomal formulations on sputum isolated from CF Patients Halwani, M.
 2009
 8 S2 p. S29-
1 p.
 artikel
5 Activity of lysosomal carboxypeptidase A, neuraminidase and glucuronidase in saliva of cystic fibrosis patients Minarowska, A.
 2009
 8 S2 p. S24-
1 p.
 artikel
6 Adherence over multiple courses of Aztreonam Lysine for Inhalation (AZLI): effect on disease-related endpoints in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA) Oermann, C.M.
 2009
 8 S2 p. S28-
1 p.
 artikel
7 A gift of Nature for the treatment of Pseudomonas aeruginosa Sandre-Ballester, C.
 2009
 8 S2 p. S29-
1 p.
 artikel
8 Agonists of peroxisome proliferator activated receptor gamma (PPARγ) modulate transepithelial anion secretion in human bronchial epithelial cells Madsen, N.
 2009
 8 S2 p. S19-
1 p.
 artikel
9 Airway Ca2+-activated Cl− channel (CaCC) activity is normal in mClca3-deficient mice Jóhannesson, B.
 2009
 8 S2 p. S63-
1 p.
 artikel
10 Airway epithelial responses to hypertonic solutions: different in vivo responses in CF and non-CF human subjects Middleton, P.G.
 2009
 8 S2 p. S22-
1 p.
 artikel
11 Airways surface liquid depletion causes MMP-12 dependent emphysema in βENaC-overexpressing mice Schubert, S.C.
 2009
 8 S2 p. S53-
1 p.
 artikel
12 Allergic inflammation produces a hypersecretory airway ion transport phenotype in mice Anagnostopoulou, P.
 2009
 8 S2 p. S54-
1 p.
 artikel
13 An aerosol decay model of Pseudomonas aeruginosa survival Clifton, I.J.
 2009
 8 S2 p. S38-
1 p.
 artikel
14 Analysis of CFTR expression in immune cell subsets of peripheral blood van Meegen, M.A.
 2009
 8 S2 p. S56-
1 p.
 artikel
15 Analysis of eNOS, TNFA, LTA, GSTM1, MBL2, ADRB2, HFE genes as modifier genes in Russian Cystic Fibrosis patients Timkovskaya, E.E.
 2009
 8 S2 p. S5-
1 p.
 artikel
16 Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin Bergamini, G.
 2009
 8 S2 p. S40-
1 p.
 artikel
17 An appropriate diagnostic approach can improve detection of CFTR mutations: the experience in Patients with Classical Form of Cystic Fibrosis coming from an Italian Region with high genetic heterogeneity Ravani, A.
 2009
 8 S2 p. S6-
1 p.
 artikel
18 Anatomopathological changes in dead children with cystic fibrosis Sciuca, S.
 2009
 8 S2 p. S109-
1 p.
 artikel
19 A new cryptic CFTR exon in mild CF Costa, C.
 2009
 8 S2 p. S2-
1 p.
 artikel
20 Anoxia prolongs the life and functionality of polymorphonuclear leukocytes Jensen, P.Ø.
 2009
 8 S2 p. S50-
1 p.
 artikel
21 Antibiotics sensitivity in mucoid and non mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients Cariani, L.
 2009
 8 S2 p. S40-
1 p.
 artikel
22 Anxiety and depression in CF patients' fathers and mothers Catastini, P.
 2009
 8 S2 p. S91-
1 p.
 artikel
23 A randomised, cross-over trial of upright sitting versus alternate side lying during nebulised delivery of medication in cystic fibrosis Dentice, R.L.
 2009
 8 S2 p. S74-
1 p.
 artikel
24 Are basal cells progenitors of the human bronchiolar epithelium? Jolly, T.
 2009
 8 S2 p. S23-
1 p.
 artikel
25 Are Cough Swabs a Valid Tool in the Adult Cystic Fibrosis Population? Lloyd, E.
 2009
 8 S2 p. S33-
1 p.
 artikel
26 Are exhaled and nasal NO measurements useful in CF adult patients? Bocherens, A.
 2009
 8 S2 p. S62-
1 p.
 artikel
27 A rheological investigation of cystic fibrosis sputum Britland, S.
 2009
 8 S2 p. S74-
1 p.
 artikel
28 Assessment of bone mass density by quantitative ultrasonography in children with cystic fibrosis Turcu, O.
 2009
 8 S2 p. S85-
1 p.
 artikel
29 Assessment of bone mineralisation in cystic fibrosis Rolin, S.A.
 2009
 8 S2 p. S83-
1 p.
 artikel
30 Assessment of respiratory compliance in infants with cystic fibrosis Pillarisetti, N.
 2009
 8 S2 p. S58-
1 p.
 artikel
31 Assessment of specific exercise for correction of postural disorders in CF patients Almajan-Guta, B.
 2009
 8 S2 p. S72-
1 p.
 artikel
32 Association between CYP3A enzyme activity and ciprofloxacin and clarithromycin pharmacokinetics in patients with cystic fibrosis Nielsen, X.
 2009
 8 S2 p. S49-
1 p.
 artikel
33 Associations between walking distance and quality of life in children with CF Nomden, J.G.
 2009
 8 S2 p. S75-
1 p.
 artikel
34 A tool to facilitate transition to adult care for young people with cystic fibrosis Renton, N.A.
 2009
 8 S2 p. S102-
1 p.
 artikel
35 A two-days full-scanning of the CFTR gene for simultaneous detection of point mutations and large rearrangements using High Resolution Melting analysis (HRM) in combination with quantitative real-time PCR Thèze, C.
 2009
 8 S2 p. S15-
1 p.
 artikel
36 Audit of deaths in a single adult CF centre Saffy, A.
 2009
 8 S2 p. S103-
1 p.
 artikel
37 Audit of hearing surveillance in UK paediatric cystic fibrosis units Wilkinson, J.D.
 2009
 8 S2 p. S107-
1 p.
 artikel
38 Author Index 2009
 8 S2 p. S113-S121
9 p.
 artikel
39 Autonomic neuropathy in cystic fibrosis Palamarthy, A.B.
 2009
 8 S2 p. S83-
1 p.
 artikel
40 A way in therapeutic education (TE) for the children with cystic fibrosis and their family Berville, C.
 2009
 8 S2 p. S97-
1 p.
 artikel
41 Azithromycin is not able to decrease inflammatory process in cystic fibrosis human bronchial epithelial cells Saint-Criq, V.
 2009
 8 S2 p. S54-
1 p.
 artikel
42 Azithromycin long term effects in children with cystic fibrosis Tamalet, A.
 2009
 8 S2 p. S66-
1 p.
 artikel
43 Better satisfaction of cystic fibrosis paediatric patients with autogenic drainage associated to exercise compared to conventional chest physiotherapy Reix, P.
 2009
 8 S2 p. S73-
1 p.
 artikel
44 Bone loss in CF: a fragmented picture Robertson, J.
 2009
 8 S2 p. S85-
1 p.
 artikel
45 Bronchiectasis (BE) on CT is a strong predictor of respiratory tract exacerbations in children with CF Loeve, M.
 2009
 8 S2 p. S68-
1 p.
 artikel
46 Bronchodilator responsiveness and IgE in pediatric cystic fibrosis patients Castanhinha, S.
 2009
 8 S2 p. S67-
1 p.
 artikel
47 Burkholderia cenocepacia: nearing the end? Spencer, E.M.
 2009
 8 S2 p. S34-
1 p.
 artikel
48 Camille and the Dragon. A magic story to explain CF disease to 3–5 year old children Francon, S.
 2009
 8 S2 p. S96-
1 p.
 artikel
49 Can Burkholderia Cepacia complex (BCC) be eradicated with nebulised Amiloride and Tobi? Ball, R.
 2009
 8 S2 p. S65-
1 p.
 artikel
50 Carbohydrate counting and insulin adjustment in Cystic Fibrosis related Diabetes Robb, L.
 2009
 8 S2 p. S82-
1 p.
 artikel
51 Cell targeting for CF gene therapy: Identification of a new specific cell ligand and selection of infectious papillomavirus mutants Carpentier, A.
 2009
 8 S2 p. S31-
1 p.
 artikel
52 CF an Immune Disease? Henke, M.O.
 2009
 8 S2 p. S50-
1 p.
 artikel
53 CF Diagnosis Announcement Practices following a neonatal screening in France Guéganton, L.J.
 2009
 8 S2 p. S13-
1 p.
 artikel
54 CF registry in Northern Greece Hatziagorou, E.
 2009
 8 S2 p. S105-
1 p.
 artikel
55 CFTR and tight junctions in cultured bronchial epithelial cells Nilsson, H.E.
 2009
 8 S2 p. S20-
1 p.
 artikel
56 CFTR gene analysis in the Western-Ukrainian population: an unusually high frequency of the 2184insA mutation Krenkova, P.
 2009
 8 S2 p. S6-
1 p.
 artikel
57 Change in composition and structure of bacteria in the CF airway over one year Stressmann, F.A.
 2009
 8 S2 p. S33-
1 p.
 artikel
58 Changes in Cystic Fibrosis mortality and persisting gender inequalities in Australia: 1979–2005 Reid, D.W.
 2009
 8 S2 p. S103-
1 p.
 artikel
59 Characteristics of Staphylococcus aureus small colony variants (SCV) in CF patients Yagci, S.
 2009
 8 S2 p. S43-
1 p.
 artikel
60 Characteristics of visual function in adults with cystic fibrosis Evans, K.S.
 2009
 8 S2 p. S83-
1 p.
 artikel
61 Characterization of bacterial strains isolated from the CF patients in Georgia and evaluation of the efficacy of phage treatment Kutateladze, M.I.
 2009
 8 S2 p. S29-
1 p.
 artikel
62 Characterization of SCC mec types involved in persistent MRSA infections in cystic fibrosis patients Cocchi, P.
 2009
 8 S2 p. S42-
1 p.
 artikel
63 Chronic bronchial infection (cbi) with Bordetella bronchiseptica (Bb) in CF Vazquez, C.
 2009
 8 S2 p. S46-
1 p.
 artikel
64 Chronic infection with Achromobacter xylosoxidans leads to rapid decrease towards end-stage lung disease in cystic fibrosis patients Hansen, C.R.
 2009
 8 S2 p. S64-
1 p.
 artikel
65 Chronic toxicity study of lancovutide in beagle dogs Wachter, C.
 2009
 8 S2 p. S28-
1 p.
 artikel
66 Click chemistry: a promising approach to improve targeting ability of non-viral pulmonary gene transfer Labas, R.
 2009
 8 S2 p. S31-
1 p.
 artikel
67 Clinical and genetic profile of patients from Moldova diagnosed with cystic fibrosis Sciuca, S.
 2009
 8 S2 p. S106-
1 p.
 artikel
68 Clinical characteristics of infants diagnosed through cystic fibrosis newborn screening (CF NBS) Sands, D.
 2009
 8 S2 p. S12-
1 p.
 artikel
69 Clinical follow-up of 13 French CF patients with Inquilinus limosus Chiron, R.
 2009
 8 S2 p. S46-
1 p.
 artikel
70 Clinical impact of a highly prevalent P. aeruginosa clone in Dutch CF patients de Vrankrijker, A.M.
 2009
 8 S2 p. S37-
1 p.
 artikel
71 Clinical Microbiology of Haemophilus influenzae in Cystic Fibrosis Fenger, M.G.
 2009
 8 S2 p. S45-
1 p.
 artikel
72 Clinical outcome in cystic fibrosis patients with or without meconium ileus Venkatesh, K.
 2009
 8 S2 p. S79-
1 p.
 artikel
73 Clinical phenotype for the G551D mutation Comer, D.M.
 2009
 8 S2 p. S6-
1 p.
 artikel
74 Clinical status at start of IV treatment and effect on daily life Strandner, K.
 2009
 8 S2 p. S94-
1 p.
 artikel
75 Clinical value of cough swab samples, versus induced sputum samples in children with cystic fibrosis Lilos, C.
 2009
 8 S2 p. S62-
1 p.
 artikel
76 Clonally identical Burkholderia cepacia complex (Bcc) sequence type strain ST32 isolated from cystic fibrosis (CF) patients in French western Brittany compared to epidemiology of Bcc strains in France using Multilocus sequence typing (MLST) Abalain, M.L.
 2009
 8 S2 p. S34-
1 p.
 artikel
77 Colistin sulfate/tobramycin combination is superior for killing biofilm P. aeruginosa than monotherapy in vitro Herrmann, G.
 2009
 8 S2 p. S41-
1 p.
 artikel
78 COMMD1 promotes CFTR trafficking through inhibition of ubiquitination Drévillon, L.
 2009
 8 S2 p. S18-
1 p.
 artikel
79 Community-Acquired MRSA causes earlier infection than Hospital-Acquired MRSA in patients with cystic fibrosis Campana, S.
 2009
 8 S2 p. S42-
1 p.
 artikel
80 Comparative study of predominant fecal microbiota of cystic fibrosis patients and healthy siblings Duytschaever, G.
 2009
 8 S2 p. S44-
1 p.
 artikel
81 Comparing six countries experience of newborn screening for CF Cowlard, J.
 2009
 8 S2 p. S13-
1 p.
 artikel
82 Comparison of biofilm formation between Burkholderia multivorans Burkholderia cenocepacia Pseudomonas aeruginosa in the presence or absence of mucin Einarsson, G.G.
 2009
 8 S2 p. S34-
1 p.
 artikel
83 Comparison of Inflammatory responses to Pseudomonas aeruginosa Lipopolysaccharide isolates compared to Staphylococcus aureus Peptidoglycan Buchanan, P.J.
 2009
 8 S2 p. S52-
1 p.
 artikel
84 Comparison of MRSA isolated from patients in two paediatric CF centres Gilpin, D.F.
 2009
 8 S2 p. S42-
1 p.
 artikel
85 Comparison of nasal potential difference measurements done on the nasal floor and under the inferior turbinate: repeatability Vermeulen, F.
 2009
 8 S2 p. S10-
1 p.
 artikel
86 Comparison of nasal potential difference measurements done on the nasal floor and under the inferior turbinate: success rate and mean values Vermeulen, F.
 2009
 8 S2 p. S10-
1 p.
 artikel
87 Comparison of the sensitivity of six PCR formats for the detection of P. aeruginosa Deschaght, P.
 2009
 8 S2 p. S36-
1 p.
 artikel
88 Complementary Therapy: Planning a service for adults with Cystic Fibrosis Hildage, J.
 2009
 8 S2 p. S75-
1 p.
 artikel
89 Complete screening of the CFTR gene in idiopathic chronic pancreatitis Masson, E.
 2009
 8 S2 p. S15-
1 p.
 artikel
90 Complete sequencing of the CFTR gene using new generation GS-FLX sequencing technology Cuppens, H.
 2009
 8 S2 p. S2-
1 p.
 artikel
91 Comprehensive analysis of the French NBS cohort: Excellent mutation detection rate despite high allelic heterogeneity des Georges, M.
 2009
 8 S2 p. S4-
1 p.
 artikel
92 Comprehensive cost comparison of newborn screening strategies with novel inclusion of costs related to genetic counseling and collection of second specimens Wells, J.M.
 2009
 8 S2 p. S12-
1 p.
 artikel
93 Conceptual approach of an educational evaluation system for patients Berville, C.
 2009
 8 S2 p. S98-
1 p.
 artikel
94 Congo Red staining of CF-related pathogens grown as biofilms in the absence or presence of mucin Einarsson, G.G.
 2009
 8 S2 p. S34-
1 p.
 artikel
95 Connexin channels mediate PGE2-dependent regulation of CFTR activity in Calu-3 cells Losa, D.
 2009
 8 S2 p. S19-
1 p.
 artikel
96 Connexin 26 is implied in the regulation of airway epithelium repair Crespin, S.
 2009
 8 S2 p. S19-
1 p.
 artikel
97 Corneal opacity: rare complication of cystic fibrosis Pekcan, S.
 2009
 8 S2 p. S107-
1 p.
 artikel
98 Correction of the F508del-CFTR function by the Gonadotropin-Releasing hormone (GnRH) in polarized and non-polarized epithelial cells Benz, N.
 2009
 8 S2 p. S18-
1 p.
 artikel
99 Cost saving potential in pharmaceutical treatment of adult patients with cystic fibrosis Baltin, C.T.
 2009
 8 S2 p. S107-
1 p.
 artikel
100 Creating a CF community – ‘CF in the City’ – a CF Newsletter Dealtry, A.
 2009
 8 S2 p. S97-
1 p.
 artikel
101 Creatinine clearance in cystic fibrosis patients: MDRD, Cockcroft-Gault and measured creatinine clearance Bronsveld, I.
 2009
 8 S2 p. S107-
1 p.
 artikel
102 CREON®: efficacy and safety in children less than 7 years old with exocrine pancreatic insufficiency due to cystic fibrosis Sander-Struckmeier, S.
 2009
 8 S2 p. S80-
1 p.
 artikel
103 Criteria for diagnosis of CF in the French Registry Lemonnier, L.
 2009
 8 S2 p. S104-
1 p.
 artikel
104 CT-detected early structural lung disease is progressive in infants and preschool children Mott, L.
 2009
 8 S2 p. S68-
1 p.
 artikel
105 Cystic Fibrosis and mitochondrial gene mutation MT-RNRI Hollsing, A.E.
 2009
 8 S2 p. S5-
1 p.
 artikel
106 Cystic Fibrosis (CF) Newborn Screening (NBS) – Comparison of an IRT-PAP with an IRT-DNA based protocol in a German population Sommerburg, O.
 2009
 8 S2 p. S9-
1 p.
 artikel
107 Cystic fibrosis Heelprick among a newbOrn Population in the Netherlands: the CHOPIN-study Vernooij-van Langen, A.M.
 2009
 8 S2 p. S9-
1 p.
 artikel
108 Cystic Fibrosis incidence in Lombardy over a seven year period Paracchini, V.
 2009
 8 S2 p. S14-
1 p.
 artikel
109 Cystic Fibrosis Questionnaire Reference Data in a healthy, Dutch population 6–20 yrs Sintnicolaas, J.C.
 2009
 8 S2 p. S99-
1 p.
 artikel
110 Cytokine pattern in broncho-alveolar lavage in children with Cystic Fibrosis and infection with Pseudomonas aeruginosa Frischer, T.
 2009
 8 S2 p. S63-
1 p.
 artikel
111 Cytokine production in the differentiating human airway epithelium Crespin, S.
 2009
 8 S2 p. S55-
1 p.
 artikel
112 Cytotoxic activity evidence of Achromobacter xylosoxidans for pulmonar tissue Levy, C.E.
 2009
 8 S2 p. S46-
1 p.
 artikel
113 Decreased expression of Nod2-receptors in cystic fibrosis airway epithelial cells Varelogianni, G.
 2009
 8 S2 p. S56-
1 p.
 artikel
114 Decreased IL-8 secretion and expression by fluvastatin in primary human macrophages and in the whole blood from adult patients with cystic fibrosis Jouneau, S.
 2009
 8 S2 p. S55-
1 p.
 artikel
115 Desaturation on 3-minute step test is associated with impaired outcomes at 12 months in adults with cystic fibrosis Holland, A.E.
 2009
 8 S2 p. S70-
1 p.
 artikel
116 Detection of anaerobic bacteria in bronchoalveolar lavage fluid from paediatric CF patients Tunney, M.M.
 2009
 8 S2 p. S45-
1 p.
 artikel
117 Detection of bile acids in sputum as a screening method for assessment of aspiration of duodenogastric contents in patients with cystic fibrosis Pauwels, A.
 2009
 8 S2 p. S78-
1 p.
 artikel
118 Developing a Portacath needle removal device Locke, Y.
 2009
 8 S2 p. S94-
1 p.
 artikel
119 Development of a low dose nasal infection model with Pseudomonas aeruginosa in mice Woelbeling, F.
 2009
 8 S2 p. S39-
1 p.
 artikel
120 Development of a secure, on-line clinical health record to improve care in cystic fibrosis (CF) Finlayson, F.A.
 2009
 8 S2 p. S108-
1 p.
 artikel
121 Distribution of Burkholderia cepacia complex genomovars from agricultural samples in French western Brittany and epidemiological significance Abalain, M.L.
 2009
 8 S2 p. S33-
1 p.
 artikel
122 Diversity of Candida spp in adult CF patients Baxter, C.
 2009
 8 S2 p. S43-
1 p.
 artikel
123 Drug specific T cells in patients with a history of non-immediate hypersensitivity reactions Whitaker, P.
 2009
 8 S2 p. S55-
1 p.
 artikel
124 Dynamics of upper and lower airway colonisation with P.aeruginosa and S.aureus in CF-patients within 3.5 years Mainz, J.G.
 2009
 8 S2 p. S64-
1 p.
 artikel
125 Early chest physical therapy (CP) programme in children with cystic fibrosis (CF) diagnosed by newborn screening (NS) Valiente, A.
 2009
 8 S2 p. S73-
1 p.
 artikel
126 Early colonization by Staphylococcus aureus and Pseudomonas aeruginosa in newborn screening children Champs, N.S.
 2009
 8 S2 p. S64-
1 p.
 artikel
127 Early detection of glucose derangement in children with Cystic Fibrosis Raia, V.
 2009
 8 S2 p. S81-
1 p.
 artikel
128 Early detection of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF) by real-time PCR (RT-PCR): original method developed for a preliminary study Héry-Arnaud, G.
 2009
 8 S2 p. S36-
1 p.
 artikel
129 Early diagnosis of glucose intolerance and/or diabetes in children with cystic fibrosis Walicka, K.
 2009
 8 S2 p. S81-
1 p.
 artikel
130 Editorial Board 2009
 8 S2 p. iii-
1 p.
 artikel
131 Education and CF: experiences of parents and schools Degelin, S.
 2009
 8 S2 p. S97-
1 p.
 artikel
132 Effective treatment of chronic Pseudomonas aeruginosa (Pa) infection with tobramycin inhalation powder in CF patients Konstan, M.W.
 2009
 8 S2 p. S27-
1 p.
 artikel
133 Effect of multiple courses of Aztreonam Lysine for Inhalation (AZLI) on FEV1 and weight in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Analysis of 18 month data from CP-AI-006 Oermann, C.M.
 2009
 8 S2 p. S28-
1 p.
 artikel
134 Effect of N-butyldeoxynojirimycin on chloride efflux from CF airway epithelial cells Oliynyk, I.
 2009
 8 S2 p. S27-
1 p.
 artikel
135 Effect of Positive Expiratory Pressure combined with Nebulization on Inhaled Dose: an In Vitro Evaluation Reychler, G.
 2009
 8 S2 p. S66-
1 p.
 artikel
136 Effects of denufosol on sinusitis-related complaints in a phase 3 trial in cystic fibrosis patients Mospan, A.R.
 2009
 8 S2 p. S26-
1 p.
 artikel
137 Efficacy and safety of a new formulation of CREON® in patients with exocrine pancreatic insufficiency due to CF Trapnell, B.C.
 2009
 8 S2 p. S80-
1 p.
 artikel
138 Efficacy of Aztreonam Lysine for Inhalation (AZLI) in patients with cystic fibrosis and drug resistant P. aeruginosa (DRPA) McCoy, K.S.
 2009
 8 S2 p. S28-
1 p.
 artikel
139 Efficacy of Bramitob® on eradication of Ps. aeruginosa (PA) Drinković, D.T.
 2009
 8 S2 p. S65-
1 p.
 artikel
140 Efficacy of slow release insulin in patients with Cystic Fibrosis and Glucide Intolerance Minicucci, L.
 2009
 8 S2 p. S82-
1 p.
 artikel
141 Efficiency of High frequency chest wall oscillation with “The Vest® Airway Clearance System” as daily physiotherapy in outpatients with CF Scherbakova, A.Y.
 2009
 8 S2 p. S73-
1 p.
 artikel
142 Electromyographic evaluation of muscular function in adults with cystic fibrosis Gruet, M.
 2009
 8 S2 p. S72-
1 p.
 artikel
143 Emotional condition of adult with cystic fibrosis (CF): implication of illness or structure of personality? Catastini, P.
 2009
 8 S2 p. S91-
1 p.
 artikel
144 Epithelial factors produced during the remodelling of the human airway epithelium Roux, J.
 2009
 8 S2 p. S23-
1 p.
 artikel
145 Eradication of methicillin resistant Staphylococcus aureus in cystic fibrosis Kappler, M.
 2009
 8 S2 p. S42-
1 p.
 artikel
146 Eradication of Pseudomonas aeruginosa in adults with CF Kenny, S.
 2009
 8 S2 p. S39-
1 p.
 artikel
147 Estimating renal function in paediatric cystic fibrosis patients Edwards, C.T.
 2009
 8 S2 p. S108-
1 p.
 artikel
148 Estimating risk associated with home-based intravenous antibiotic therapy (IVAT) Glasscoe, C.
 2009
 8 S2 p. S95-
1 p.
 artikel
149 Estrogen and phytoestrogens increase the CFTR and F508del CFTR expression and function Hamdaoui, N.
 2009
 8 S2 p. S18-
1 p.
 artikel
150 ETR-3 is a major regulator of CFTR pre-mRNA splicing Dujardin, G.
 2009
 8 S2 p. S1-
1 p.
 artikel
151 EuroCareCF European Microbiology Quality Assurance Trials Hogardt, M.
 2009
 8 S2 p. S33-
1 p.
 artikel
152 European survey on schooling of children, teenagers and young adults with cystic fibrosis Sermet-Gaudelus, I.
 2009
 8 S2 p. S98-
1 p.
 artikel
153 Evaluation and management of fungal risk in Cystic Fibrosis: first results of a national French study Leroy, S.
 2009
 8 S2 p. S44-
1 p.
 artikel
154 Evaluation of a new nutritional score in patients with cystic fibrosis Alicandro, G.
 2009
 8 S2 p. S85-
1 p.
 artikel
155 Evaluation of a new tool for measurement of sweat chloride concentration Hubert, D.
 2009
 8 S2 p. S10-
1 p.
 artikel
156 Evaluation of a novel chromogenic medium for isolation and characterization of Pseudomonas aeruginosa from the sputa of cystic fibrosis (CF) patients Fournier, D.
 2009
 8 S2 p. S35-
1 p.
 artikel
157 Evaluation of European protocols for measuring nasal potential differences Bronsveld, I.
 2009
 8 S2 p. S10-
1 p.
 artikel
158 Evaluation of oxidant and antioxidant status in CFTR-KO mice: role of Peroxiredoxin 6 Trudel, S.
 2009
 8 S2 p. S53-
1 p.
 artikel
159 Evaluation of two different timings of Pulmozyme nebulisation in relation to chest physiotherapy in children with Cystic Fibrosis Anderson, P.
 2009
 8 S2 p. S74-
1 p.
 artikel
160 Evidence of aminoglycoside cochleotoxicity measured by standard & high frequency audiometry and Distortion-Product otoacoustic emissions in paediatric Cystic Fibrosis patients Al-Malky, G.
 2009
 8 S2 p. S48-
1 p.
 artikel
161 Exonic sequence variations affecting splicing within exons 3, 4 and 5 Hinzpeter, A.
 2009
 8 S2 p. S1-
1 p.
 artikel
162 Expectoration of sputum – a simple concept becomes a troublesome issue? Riley, D.W.
 2009
 8 S2 p. S75-
1 p.
 artikel
163 Experience of a 1 year therapeutic education program Clairicia, M.
 2009
 8 S2 p. S98-
1 p.
 artikel
164 Experience of parents of CF pre-teenagers participating in a therapeutic education program Varlet, V.
 2009
 8 S2 p. S96-
1 p.
 artikel
165 Exploration of personality, psychosocial factors and illness effect on adherence behaviour in CF Braithwaite, M.
 2009
 8 S2 p. S92-
1 p.
 artikel
166 Expression of Unfolded Protein Response (UPR) protein markers are increased in primary and cystic fibrosis (CF) nasal polyposis (NP) Jeanson, L.
 2009
 8 S2 p. S22-
1 p.
 artikel
167 Extensive carrier testing and CF birth prevalence: evidence for a negative correlation Castellani, C.
 2009
 8 S2 p. S104-
1 p.
 artikel
168 Factors influencing the worsening of lung function between 16 and 18 years of age in Czech patients Zemkova, D.
 2009
 8 S2 p. S59-
1 p.
 artikel
169 FEV1 rate of decline in CF patients: towards zero overa8years period Leonard, A.
 2009
 8 S2 p. S61-
1 p.
 artikel
170 Fibrosis blood tests to detect liver disease in patients with cystic fibrosis Wagner, A.C.
 2009
 8 S2 p. S77-
1 p.
 artikel
171 Final results of a 14- and 28-day study of VX-770 in subjects with CF Accurso, F.J.
 2009
 8 S2 p. S25-
1 p.
 artikel
172 First colonisation with P. aeruginosa – only detected in the upper airways – eradicated with sinonasal inhalation of Tobramycin Mainz, J.G.
 2009
 8 S2 p. S69-
1 p.
 artikel
173 First results of preimplantation genetic diagnosis of cystic fibrosis in Russia Basanov, P.A.
 2009
 8 S2 p. S16-
1 p.
 artikel
174 Flavonoides increase chloride conductance at the apical membrane of the respiratory epithelium in some CF-patients Geidel, C.
 2009
 8 S2 p. S27-
1 p.
 artikel
175 Foreword Férec, Claude
 2009
 8 S2 p. v-
1 p.
 artikel
176 Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes Sorio, C.
 2009
 8 S2 p. S22-
1 p.
 artikel
177 Fungal allergy in adult cystic fibrosis Baxter, C.
 2009
 8 S2 p. S44-
1 p.
 artikel
178 Gallbladder dysfunction contributes to impaired bile salt homeostasis in cystic fibrosis Debray, D.
 2009
 8 S2 p. S78-
1 p.
 artikel
179 Gastro-oesophageal reflux and gastric emptying in children with cystic fibrosis Hauser, B.
 2009
 8 S2 p. S78-
1 p.
 artikel
180 Genetic aspect of two-year experience in cystic fibrosis newborn screening program in Poland Norek, A.
 2009
 8 S2 p. S14-
1 p.
 artikel
181 Genotype based evaluation of eradication treatment of new P. aeruginosa infections in CF patients Schelstraete, P.
 2009
 8 S2 p. S39-
1 p.
 artikel
182 Genotyping of Pseudomonas aeruginosa isolates can predict the transition to chronic colonization in CF patients Schelstraete, P.
 2009
 8 S2 p. S40-
1 p.
 artikel
183 Genotyping of Pseudomonas aeruginosa isolates from aquatic environment at a Swedish hospital and relation to infection of lung transplanted patients with Pseudomonas Johansson, E.
 2009
 8 S2 p. S38-
1 p.
 artikel
184 Health care costs in the management of pregnant CF women Ponnuswamy, A.
 2009
 8 S2 p. S108-
1 p.
 artikel
185 Heart assessment during exercise can predict pulmonary hypertension (PH) in CF? Favilli, S.
 2009
 8 S2 p. S60-
1 p.
 artikel
186 Heart rate recovery in young adult patients with cystic fibrosis Sahlberg, M.
 2009
 8 S2 p. S71-
1 p.
 artikel
187 Hepatic tissue TGF-β and SMAD proteins as markers of the fibrosing process in cystic fibrosis: a pilot study Sotiriadou, F.
 2009
 8 S2 p. S77-
1 p.
 artikel
188 Histidinylated linear PEIs as new DNA carriers for in vitro and in vivo gene transfer with low toxicity Guégan, P.
 2009
 8 S2 p. S30-
1 p.
 artikel
189 How we managed to improve a professional attitude in the nursing team to deal with topics of sexuality, fertility and reproduction in relation to CF patients van Hattem, M.
 2009
 8 S2 p. S102-
1 p.
 artikel
190 HRCT and LFT in monitoring CF lung disease Polakovič, M.
 2009
 8 S2 p. S67-
1 p.
 artikel
191 Human Neutrophil Peptide-1 (HNP-1) and a truncated analogue display antimicrobial activity against respiratory pathogens Lundy, F.T.
 2009
 8 S2 p. S47-
1 p.
 artikel
192 IBW < 85% in the first year of life and pulmonary manifestations at 6 years old, in patients with cystic fibrosis Mosescu, S.
 2009
 8 S2 p. S86-
1 p.
 artikel
193 Identification of a novel frameshift mutation in CFTR gene: description, and clinical data Gaillyová, R.
 2009
 8 S2 p. S6-
1 p.
 artikel
194 Identification of CFTR rearrangements by a CGH locus specific array Quéméner, S.
 2009
 8 S2 p. S15-
1 p.
 artikel
195 Identification of large deletions and duplications in the CFTR gene using Multiple Ligation-dependent Probe Assay (MLPA), including one novel duplication and two novel deletions Bulman, M.
 2009
 8 S2 p. S3-
1 p.
 artikel
196 Immunity in CF associated liver disease Ciuca, I.M.
 2009
 8 S2 p. S77-
1 p.
 artikel
197 Immuno-Reactive Trypsine and extern pancreatic status in cystic fibrosis children Chaillou, E.
 2009
 8 S2 p. S79-
1 p.
 artikel
198 Impact of allergic sensitization on CF-associated chronic rhinosinusitis – Results from a multicentre interdisciplinary study Dopfer, C.
 2009
 8 S2 p. S108-
1 p.
 artikel
199 Impact of polymers on lipid cationic mediated gene transfer Chèvre, R.
 2009
 8 S2 p. S31-
1 p.
 artikel
200 Impact of strict anaerobs on the pathogenesis of lung infection in patients with Cystic Fibrosis Ulrich, M.
 2009
 8 S2 p. S45-
1 p.
 artikel
201 Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis Mafficini, A.
 2009
 8 S2 p. S4-
1 p.
 artikel
202 Implementation of the UK Newborn Screening Programme Southern, K.W.
 2009
 8 S2 p. S11-
1 p.
 artikel
203 Implementation, uptake and impact of a cystic fibrosis electronic patient record system Peckham, D.
 2009
 8 S2 p. S109-
1 p.
 artikel
204 Improvement in aerobic fitness and quality of life does not depend on severity of pulmonary disease in CF patients Jung, A.
 2009
 8 S2 p. S60-
1 p.
 artikel
205 Improvement of intestinal comfort in cystic fibrosis patients after probiotics consumption del Campo, R.
 2009
 8 S2 p. S89-
1 p.
 artikel
206 Improving self efficacy in adolescents and young adults with cystic fibrosis (CF) Wainwright, C.
 2009
 8 S2 p. S93-
1 p.
 artikel
207 Incidence of the CFTR exon 9 and its flanking sequence duplication on the mutation diagnosis in CF patients EL-Seedy, A.
 2009
 8 S2 p. S12-
1 p.
 artikel
208 Inconclusive CF diagnosis in Neonatal Screening Colón, C.
 2009
 8 S2 p. S13-
1 p.
 artikel
209 Increased allergic bronchopulmonary aspergillosis (ABPA) in CF – a result of global warming? Ponnuswamy, A.
 2009
 8 S2 p. S57-
1 p.
 artikel
210 Increased interaction of F508del-CFTR with K8/K18 cytokeratin network by direct binding of K8 to NBD1 Colas, J.
 2009
 8 S2 p. S21-
1 p.
 artikel
211 Increased susceptibility to allergic airway inflammation in a murine model of cystic fibrosis lung disease Duerr, J.
 2009
 8 S2 p. S53-
1 p.
 artikel
212 Infection by Nocardia farcinica in CF Beucher, J.
 2009
 8 S2 p. S69-
1 p.
 artikel
213 Influence of CFTR mutations on bactericidal activity of human macrophages Socci, V.
 2009
 8 S2 p. S56-
1 p.
 artikel
214 Inhibition of cathepsins B and L by kininogens: a molecular investigation Naudin, C.
 2009
 8 S2 p. S57-
1 p.
 artikel
215 Interim outcomes of a Pseudomonas aeruginosa (Pa) eradication protocol in young children in the Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) Study Cheney, J.
 2009
 8 S2 p. S39-
1 p.
 artikel
216 International benchmarking for cystic fibrosis patient outcomes using registry data Sims, G.C.
 2009
 8 S2 p. S103-
1 p.
 artikel
217 Intestinal Current Measurement (ICM) in Europe: towards a harmonised protocol for clinical trials in cystic fibrosis Derichs, N.
 2009
 8 S2 p. S32-
1 p.
 artikel
218 Intestinal inflammation is present in young infants with cystic fibrosis Lisowska, A.
 2009
 8 S2 p. S79-
1 p.
 artikel
219 Investigation into the potential of sub-lethal photodynamic antimicrobial chemotherapy (PACT) to reduce susceptibility of Pseudomonas aeruginosa to antibiotics Cassidy, C.M.
 2009
 8 S2 p. S48-
1 p.
 artikel
220 In vitro activity of tigecycline and other antibiotics against Burkholderia cepacia complex (Bcc) and other cystic fibrosis (CF)-associated Gram negative bacteria Kenning, J.
 2009
 8 S2 p. S35-
1 p.
 artikel
221 In-vitro inhibition of neutrophil elastase activity by inhaled antibiotics used in cystic fibrosis patients Hector, A.
 2009
 8 S2 p. S63-
1 p.
 artikel
222 In vivo and in vitro effect of E831X mutation Hinzpeter, A.
 2009
 8 S2 p. S4-
1 p.
 artikel
223 IP-10 induction after LPS stimulation is compromised in cystic fibrosis bronchial epithelial cells Henke, M.O.
 2009
 8 S2 p. S55-
1 p.
 artikel
224 Is dietetics the cinderella of the CF multidisciplinary team? Lake, E.
 2009
 8 S2 p. S88-
1 p.
 artikel
225 Is enough attention paid to diet, weight and digestion? Lake, E.
 2009
 8 S2 p. S88-
1 p.
 artikel
226 Is it safe and practical to give once daily IV tobramycin to young people with cystic fibrosis at home? Lawrence, C.A.
 2009
 8 S2 p. S94-
1 p.
 artikel
227 Is 3-nitrotyrosine a marker of inflammation in airways of patients with cystic fibrosis? Ulrich, M.
 2009
 8 S2 p. S51-
1 p.
 artikel
228 8-isoprostaglandinF-2-alfa in urine as a marker of oxidative stress in cystic fibrosis patients. A longitudinal study Schiøtz, P.O.
 2009
 8 S2 p. S51-
1 p.
 artikel
229 Is quorum sensing related to strain type in Pseudomonas aeruginosa Frerichs, C.
 2009
 8 S2 p. S38-
1 p.
 artikel
230 Itraconazole (ITZ) resistant Aspergillus fumigatus (Af) in CF patients Reijers, M.
 2009
 8 S2 p. S44-
1 p.
 artikel
231 Lack of Differences in Mutant Prevention Concentration Rates Between Cystic Fibrosis Pseudomonas aeruginosa Isolates in Planktonic and Biofilm Type of Growth Garcia-Castillo, M.
 2009
 8 S2 p. S40-
1 p.
 artikel
232 Lactate as a non-invasive marker of CF lung inflammation Bensel, T.
 2009
 8 S2 p. S62-
1 p.
 artikel
233 Large antibacterial spectrum of aminosterols derivatives towards multidrug resistant Gram-negative and Gram-positive bacteria from patients with cystic fibrosis Alhanout, K.
 2009
 8 S2 p. S47-
1 p.
 artikel
234 Listing patients to lung transplantation (LTx). Experience of 110 cases in the CF Center of Verona Assael, B.M.
 2009
 8 S2 p. S59-
1 p.
 artikel
235 Long acting β2-agonist and corticosteroid restore airway glandular cell functionality altered by Staphylococcus aureus virulence factors Zahm, J.M.
 2009
 8 S2 p. S23-
1 p.
 artikel
236 Long term impact of azithromycin in paediatric cystic fibrosis patients Fermeiro, J.
 2009
 8 S2 p. S65-
1 p.
 artikel
237 Lung defense against Pseudomonas aeruginosa: the recognition by host cells of either LPS or flagellin is necessary and sufficient Raoust, E.
 2009
 8 S2 p. S52-
1 p.
 artikel
238 Lung delivery of a new tobramycin nebuliser solution (150 mg/1.5 ml) by an investigational eFlow® nebuliser is equivalent to TOBI® but in a fraction of time Denk, O.
 2009
 8 S2 p. S66-
1 p.
 artikel
239 Lung function variability in cystic fibrosis Jifon, G.
 2009
 8 S2 p. S61-
1 p.
 artikel
240 Lung transplantation in Burkholderia and Ralstonia infected CF patients Segonds, C.
 2009
 8 S2 p. S35-
1 p.
 artikel
241 Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection Gilljam, M.
 2009
 8 S2 p. S69-
1 p.
 artikel
242 MALDI-TOF mass spectrometry-based assay for CFTR gene mutation analysis in cystic fibrosis newborn screening programs Raña-Díez, P.
 2009
 8 S2 p. S3-
1 p.
 artikel
243 Mathematical modelling of FEV1% allows early recognition of patients at risk Gatti, F.
 2009
 8 S2 p. S58-
1 p.
 artikel
244 Mathematical modelling of oxygen uptake during recovery from exercise Stevens, D.
 2009
 8 S2 p. S70-
1 p.
 artikel
245 Mentoring people with cystic fibrosis: evaluation of the preparation and process Jessup, M.
 2009
 8 S2 p. S97-
1 p.
 artikel
246 Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli Segonds, C.
 2009
 8 S2 p. S35-
1 p.
 artikel
247 Microbiological characteristics of Achromobacter xylosoxidans isolated from patients with cystic fibrosis Levy, C.E.
 2009
 8 S2 p. S45-
1 p.
 artikel
248 Mineral bone density in children and bone status of adults with cystic fibrosis Colin, E.
 2009
 8 S2 p. S85-
1 p.
 artikel
249 Mitochondrial glutathione and decreased complex I activity in cystic fibrosis models Kelly, M.
 2009
 8 S2 p. S23-
1 p.
 artikel
250 Modeling of the whole CFTR 3D structure and its conformational transitions Mornon, J.P.
 2009
 8 S2 p. S17-
1 p.
 artikel
251 Molecular basis of cystic fibrosis in Republic of Macedonia: An update Fustik, S.
 2009
 8 S2 p. S7-
1 p.
 artikel
252 Molecular dissection of the MPB interacting site of CFTR Billet, A.
 2009
 8 S2 p. S18-
1 p.
 artikel
253 Molecular mechanisms of the pro-inflammatory role of membrane-associated PR3 during neutrophil apoptosis in cystic fibrosis Gabillet, J.
 2009
 8 S2 p. S56-
1 p.
 artikel
254 Molecular typing of Ps. aeruginosa direct from clinical specimens McCulloch, E.
 2009
 8 S2 p. S38-
1 p.
 artikel
255 Monitoring of the Initial Pseudomonas aeruginosa Colonization in Cystic Fibrosis Patients Demonstrated High Clonal Diversity Fernández-Olmos, A.
 2009
 8 S2 p. S37-
1 p.
 artikel
256 Monitoring of Tobramycin Levels by Fingerprick Sampling Jones, A.M.
 2009
 8 S2 p. S48-
1 p.
 artikel
257 Mortality study in a cohort of patients born since 1970 in Brittany (France) Duguépéroux, I.
 2009
 8 S2 p. S103-
1 p.
 artikel
258 MRSA and macrolide resistant Staphylococcus aureus colonization rates in a Turkish CF center Dogan, O.
 2009
 8 S2 p. S41-
1 p.
 artikel
259 Multicenter prospective study about complications of totally implantable central venous access ports in Italian people with CF: preliminary results Dal Molin, A.
 2009
 8 S2 p. S95-
1 p.
 artikel
260 Musculoskeletal problems in Cystic Fibrosis Marent-Huber, M.
 2009
 8 S2 p. S72-
1 p.
 artikel
261 Mutation analysis of CFTR gene in Slovak CF patients Soltysova, A.
 2009
 8 S2 p. S8-
1 p.
 artikel
262 Neonatal CF screening (2003–2008) in the Aquitaine region in France: high probability of a second CFTR gene mutation in heterozygotes with subnormal sweat tests Iron, A.
 2009
 8 S2 p. S13-
1 p.
 artikel
263 Neutrophil elastase: its activity and content, the levels of anti-elastase in children with bronchopulmonary diseases Gorinova, Y.V.
 2009
 8 S2 p. S63-
1 p.
 artikel
264 Neutrophil Extracellular Traps impair the inhibition of elastase, protease 3 and cathepsin G in neutrophil suspensions from CF patients Attucci, S.
 2009
 8 S2 p. S51-
1 p.
 artikel
265 Newborn screening for cystic fibrosis in Sicily (Italy): more benefits than harms Vieni, G.
 2009
 8 S2 p. S14-
1 p.
 artikel
266 New method for charting pulmonary function history Lee, Y.W.
 2009
 8 S2 p. S109-
1 p.
 artikel
267 New putative cis-acting regulatory variations in the CFTR gene Viart, V.
 2009
 8 S2 p. S1-
1 p.
 artikel
268 New targeting method for nucleic acid transfer into the lung Beilvert, F.
 2009
 8 S2 p. S30-
1 p.
 artikel
269 Non-adherence as coping strategy of young adult patients with CF. A qualitative study Seitz, G.R.
 2009
 8 S2 p. S93-
1 p.
 artikel
270 Nonclassic Cystic Fibrosis in subjects with D1152H CFTR mutation Burgel, P.R.
 2009
 8 S2 p. S5-
1 p.
 artikel
271 Nuclear delivery of DNA/histidine-polymer complexes: confocal microscopy real time investigation of the nuclear import of a plasmid DNA containing an optimized DNA κB sequence Breuzard, G.
 2009
 8 S2 p. S32-
1 p.
 artikel
272 Occurrence of complex CFTR alleles, revealed by extensive mutational analysis, can account for high sweat test variability Lucarelli, M.
 2009
 8 S2 p. S5-
1 p.
 artikel
273 Ochrobactrum and Agrobacterium spp.: emerging opportunistic pathogens in cystic fibrosis patients? Teyssier, C.
 2009
 8 S2 p. S47-
1 p.
 artikel
274 Open monitoring of adherence; is it better in those patients who bring their device for download? McCormack, P.
 2009
 8 S2 p. S92-
1 p.
 artikel
275 Optimizing aerosol administration in Cystic Fibrosis and Asthma treatment with improved Smart Card technology Kroneberg, P.
 2009
 8 S2 p. S32-
1 p.
 artikel
276 Orphan drug designation to Anti-pseudomonas IgY Nilsson, E.
 2009
 8 S2 p. S29-
1 p.
 artikel
277 Osteoporosis and osteopenia in adults with cystic fibrosis: prevalence, associated factors and biological markers interest Leroy, S.
 2009
 8 S2 p. S84-
1 p.
 artikel
278 Osteoporosis and vertebral fractures in CF patients after lung transplantation Zweytick, B.
 2009
 8 S2 p. S59-
1 p.
 artikel
279 Ototoxicity in Adults with Cystic Fibrosis Payne, N.K.
 2009
 8 S2 p. S48-
1 p.
 artikel
280 Outcome in Cystic Fibrosis Liver Disease Rowland, M.
 2009
 8 S2 p. S77-
1 p.
 artikel
281 Outreach clinics for the provision of specialist cystic fibrosis (CF) care to remote areas Doe, S.J.
 2009
 8 S2 p. S109-
1 p.
 artikel
282 Over-representation of NFκβ binding sites in CF human airway epithelial spheroid genes vs. nonCF Solem, E.J.
 2009
 8 S2 p. S1-
1 p.
 artikel
283 Overview of autopsy for CF patients: The organs weight analysis Lee, J.
 2009
 8 S2 p. S110-
1 p.
 artikel
284 Pain in CF: a national survey on 1104 patients Ravilly, S.
 2009
 8 S2 p. S100-
1 p.
 artikel
285 Pancreatic status in cystic fibrosis patients depending upon phenotype-genotype correlations Bober, L.
 2009
 8 S2 p. S79-
1 p.
 artikel
286 Paranasal sinuses are a focus for P. aeruginosa (PA) lung infection in CF Johansen, H.K.
 2009
 8 S2 p. S36-
1 p.
 artikel
287 Patient satisfaction in a District General Hospital cystic fibrosis service Johnstone, A.
 2009
 8 S2 p. S110-
1 p.
 artikel
288 Patient satisfaction in CF clinics – results from focus groups Stahl, K.
 2009
 8 S2 p. S100-
1 p.
 artikel
289 Patient satisfaction survey of the annual review service at a regional adult cystic fibrosis (CF) centre Evans, C.
 2009
 8 S2 p. S99-
1 p.
 artikel
290 Patients homozygous for F508del are not different at the beginning Homola, L.
 2009
 8 S2 p. S14-
1 p.
 artikel
291 Patients perspective of our CF related diabetes (CFRD) service Singaroyan, N.
 2009
 8 S2 p. S110-
1 p.
 artikel
292 PDZ protein interaction: the missing link between CFTR and mucins Pelaseyed, T.
 2009
 8 S2 p. S20-
1 p.
 artikel
293 Pedagogic drivers in therapeutic education for patients with cystic fibrosis Berville, C.
 2009
 8 S2 p. S98-
1 p.
 artikel
294 Peripherally Inserted Central Catheter (PICC) for home IV therapy: a Belgian CF center experience Wustefeld, F.
 2009
 8 S2 p. S94-
1 p.
 artikel
295 Perks and pitfalls of interstitial glucose monitoring – early experience from an ongoing pilot study Helm, J.M.
 2009
 8 S2 p. S81-
1 p.
 artikel
296 Pharmacokinetics and antibacterial activity of inhaled liposomal ciprofloxacin hydrochloride in healthy volunteers and in cystic fibrosis (CF) patients Bruinenberg, P.
 2009
 8 S2 p. S49-
1 p.
 artikel
297 Pharmacokinetics of tobramycin (TOBI™) after 4 and 8 weeks of continuous once daily or twice daily inhalation Rietschel, E.
 2009
 8 S2 p. S27-
1 p.
 artikel
298 Pharmacological characterization of a novel water-soluble activator of F508del-CFTR Bertrand, J.
 2009
 8 S2 p. S25-
1 p.
 artikel
299 Pharmacological inhibition of CFTR modifies cyclooxygenase-1 and -2 expression and PGD2 production in Calu-3 cells Baudouin-Legros, M.
 2009
 8 S2 p. S21-
1 p.
 artikel
300 Physical activity scoring and exercise capacity in adult CF patients Morris, A.
 2009
 8 S2 p. S71-
1 p.
 artikel
301 Physiotherapy: understanding the cough and spit Cox, N.S.
 2009
 8 S2 p. S73-
1 p.
 artikel
302 Pilot study: impact of Cystic Fibrosis on emotional and marital satisfaction Parent, A.
 2009
 8 S2 p. S91-
1 p.
 artikel
303 Plasma amino acid levels in cystic fibrosis patients Ioannou, H.P.
 2009
 8 S2 p. S88-
1 p.
 artikel
304 Polish National CF Registry – preliminary report Stezowska-Kubiak, S.
 2009
 8 S2 p. S105-
1 p.
 artikel
305 Powerful strategy permits to rapidly characterise breakpoint junctions: essential for a better understanding of the molecular mechanism involving large rearrangements Guittard, C.
 2009
 8 S2 p. S3-
1 p.
 artikel
306 Preclinical study of a new antibiotic for nebulization Vecellio, L.
 2009
 8 S2 p. S66-
1 p.
 artikel
307 Pre-flight evaluation of adult patients with cystic fibrosis Edvardsen, E.
 2009
 8 S2 p. S61-
1 p.
 artikel
308 Pregnancy and CF: Differing perspectives of patients and caregivers Eisenstadt, I.
 2009
 8 S2 p. S102-
1 p.
 artikel
309 Preimplantation genetic diagnosis for cystic fibrosis Fernandez, C.
 2009
 8 S2 p. S16-
1 p.
 artikel
310 Preparing practitioners to meet the challenges of a specialist service. A joint venture between Bristol regional CF centres and University West of England Dyer, J.
 2009
 8 S2 p. S110-
1 p.
 artikel
311 Prevalence and clinical significance of autoantibodies in 144 adult patients with cystic fibrosis Lachenal, F.
 2009
 8 S2 p. S50-
1 p.
 artikel
312 Prevalence of bone demineralisation in Russian adult CF patients and associated risk factors Krasovskiy, S.
 2009
 8 S2 p. S111-
1 p.
 artikel
313 Prevalence of bone mass density loss in cystic fibrosis patients with progressive lung disease Zweytick, B.
 2009
 8 S2 p. S61-
1 p.
 artikel
314 Prevalence of preclinical AA-amyloidosis in CF patients with chronic P. aeruginosa infection Kötz, K.
 2009
 8 S2 p. S53-
1 p.
 artikel
315 Prevalence of renal impairment in children with cystic fibrosis (CF) Andrieux, A.
 2009
 8 S2 p. S111-
1 p.
 artikel
316 Prevention of initial P. aeruginosa infection in children with cystic fibrosis: a multi-centre double-blind randomised controlled trial Tramper-Stranders, G.
 2009
 8 S2 p. S37-
1 p.
 artikel
317 Proficiency Testing for CF Newborn Screening Earley, M.C.
 2009
 8 S2 p. S11-
1 p.
 artikel
318 Proof of principle. Treatment of cystic fibrosis-related diabetes: a possible role for complementary metformin? van den Berg, J.M.
 2009
 8 S2 p. S82-
1 p.
 artikel
319 Prostaglandin E2 in exhaled breath condensate in cystic fibrosis Fila, L.
 2009
 8 S2 p. S52-
1 p.
 artikel
320 Proteinuria in patients with cystic fibrosis: is there an association with genotype? Gamboa, F.I.
 2009
 8 S2 p. S111-
1 p.
 artikel
321 Proteomic analysis of G551D and R117H-CFTR associated proteins Teng, L.
 2009
 8 S2 p. S20-
1 p.
 artikel
322 Providing inpatient education on a segregated ward Steel, J.
 2009
 8 S2 p. S96-
1 p.
 artikel
323 Provision of dietetic care in CF centres in the UK Morton, A.
 2009
 8 S2 p. S89-
1 p.
 artikel
324 Psychopathology in Turkish children and adolescents with diagnosis of cystic fibrosis Dinc, G. Senses
 2009
 8 S2 p. S90-
1 p.
 artikel
325 PTs' role in the caring of CF patients in France in 2009 Lejosne, C.
 2009
 8 S2 p. S76-
1 p.
 artikel
326 Quality improvement in newborn screening for cystic fibrosis by process failure mode effects analysis (PFMEA) Farrell, P.M.
 2009
 8 S2 p. S9-
1 p.
 artikel
327 Quality of Care and Quality of Life: Patient/Healthcare Perspectives Armoni, S.
 2009
 8 S2 p. S99-
1 p.
 artikel
328 Quality of life in children with CF and their parents Nomden, J.G.
 2009
 8 S2 p. S100-
1 p.
 artikel
329 Randomised, double blind, placebo-controlled Phase III Study of Bronchitol (inhaled dry powder mannitol) in Cystic Fibrosis (CF) Bilton, D.
 2009
 8 S2 p. S25-
1 p.
 artikel
330 Rationale for a low dose liposomal Ciclosporin A for inhalation via a customised eFlow® electronic nebuliser to prevent and treat bronchiolitis obliterans (BO) Keller, M.
 2009
 8 S2 p. S67-
1 p.
 artikel
331 Reactive hypoglycemia in non-diabetic cystic fibrosis patients van den Berg, J.M.
 2009
 8 S2 p. S82-
1 p.
 artikel
332 Re-audit of Cystic Fibrosis inpatient blood glucose monitoring with the unit policy Robb, L.
 2009
 8 S2 p. S81-
1 p.
 artikel
333 Reconsidering self-care: a sociological response to CF research Greenop, D.T.
 2009
 8 S2 p. S92-
1 p.
 artikel
334 Rectal prolapse in CF: a population study Scott-Jupp, R.
 2009
 8 S2 p. S104-
1 p.
 artikel
335 Reference values for maximal aerobic exercise capacity in children with cystic fibrosis van Leeuwen, P.
 2009
 8 S2 p. S70-
1 p.
 artikel
336 Refinement of CFTR transmembrane segments by a novel prediction tool Paulet, D.
 2009
 8 S2 p. S17-
1 p.
 artikel
337 Regulation of mucin 5AC expression by arachidonic acid metabolites Garcia-Verdugo, I.
 2009
 8 S2 p. S20-
1 p.
 artikel
338 Relationship between pulmonary exacerbations and lung function decline in a six month trial of denufosol Accurso, F.J.
 2009
 8 S2 p. S26-
1 p.
 artikel
339 Requirement of endosomal SNARE protein complex in CFTR activity/trafficking regulation Clément, R.
 2009
 8 S2 p. S21-
1 p.
 artikel
340 Rescue of A455E CFTR by temperature, small molecule correctors and transcomplementation Cebotaru, L.
 2009
 8 S2 p. S17-
1 p.
 artikel
341 Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 Van Goor, F.
 2009
 8 S2 p. S17-
1 p.
 artikel
342 Resistance in cystic fibrosis Pseudomonas aeruginosa strains is not mediated by common acquired antibiotic resistance genes Pirnay, J.P.
 2009
 8 S2 p. S41-
1 p.
 artikel
343 Resistance mechanisms to β-lactams in cystic fibrosis (CF) Pseudomonas aeruginosa isolates: a French Multicentre Study Llanes, C.
 2009
 8 S2 p. S41-
1 p.
 artikel
344 Respiratory exacerbations and muscle strength in adult patients with cystic fibrosis Vrijsen, B.
 2009
 8 S2 p. S72-
1 p.
 artikel
345 Respiratory exacerbations in children aged 0–3 years in the Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) Study Byrnes, C.A.
 2009
 8 S2 p. S60-
1 p.
 artikel
346 Revealing potential plasma lipid biomarkers of cystic fibrosis by mass spectrometry Guerrera, C.
 2009
 8 S2 p. S9-
1 p.
 artikel
347 Risk factors for poor outcomes in Cystic Fibrosis – 10 years of challenging experience in Eastern Europe Dracea, L.L.
 2009
 8 S2 p. S12-
1 p.
 artikel
348 Role of COMMD1 and CSN5 in transcriptional regulation of the CFTR gene de Becdelièvre, A.
 2009
 8 S2 p. S50-
1 p.
 artikel
349 Role of cytosolic phospholipase A2 in Pseudomonas aeruginosa-induced inflammation Wu, Y.
 2009
 8 S2 p. S52-
1 p.
 artikel
350 Roscovitine: a novel corrector for the functional rescue of F508del-CFTR protein Norez, C.
 2009
 8 S2 p. S26-
1 p.
 artikel
351 Safety/Efficacy of Inhaled Human Alpha-1 Antitrypsin (AAT) in CF: A Phase II Clinical Study Kerem, E.
 2009
 8 S2 p. S25-
1 p.
 artikel
352 School visits should be an integral part of the CF CNS service Cowlard, J.
 2009
 8 S2 p. S101-
1 p.
 artikel
353 Search for population-specific CFTR mutations: How to avoid the identification of unclassified variants Altieri, J.P.
 2009
 8 S2 p. S4-
1 p.
 artikel
354 Segregation of children 5 and under diagnosed via newborn screening does not prevent acquisition of P. aeruginosa McKay, K.
 2009
 8 S2 p. S37-
1 p.
 artikel
355 Self-care: a qualitative study of adults with CF Greenop, D.T.
 2009
 8 S2 p. S91-
1 p.
 artikel
356 Sequence and MLPA analyses found CFTR mutations in all patients with classic CF de Monestrol, I.
 2009
 8 S2 p. S3-
1 p.
 artikel
357 Sequential bronchoscopy in the management of patients with lobar atelectasis Whitaker, P.
 2009
 8 S2 p. S69-
1 p.
 artikel
358 Serum tobramycin levels following delivery of tobramycin (TOBI®) via eFlow advanced nebuliser in children with cystic fibrosis Guy, E.L.
 2009
 8 S2 p. S47-
1 p.
 artikel
359 Should Cystic Fibrosis patients be transplanted using “suboptimal organs”: insights from decision analysis Thomas, A.
 2009
 8 S2 p. S59-
1 p.
 artikel
360 Singing and Cystic Fibrosis: A pilot experience at Centre de Perharidy (Roscoff, France) Dirou, A.
 2009
 8 S2 p. S75-
1 p.
 artikel
361 SiRNA calnexin promotes endogenous F508del-CFTR trafficking Raveau, D.
 2009
 8 S2 p. S19-
1 p.
 artikel
362 Sodium depletion in infants diagnosed with CF Crocker, J.
 2009
 8 S2 p. S87-
1 p.
 artikel
363 Soluble transferrin receptor for evaluating iron status in cystic fibrosis Karlge-Nilsson, E.
 2009
 8 S2 p. S87-
1 p.
 artikel
364 Spectrum of CFTR mutations in northern Portugal patients with CF and related phenotypes Grangeia, A.
 2009
 8 S2 p. S7-
1 p.
 artikel
365 Spirometry and Impulse Oscillation measurements in children with cystic fibrosis (CF) Bridge, P.D.
 2009
 8 S2 p. S58-
1 p.
 artikel
366 Sputum eosinophils are elevated in CF patients with asthma Decraene, A.
 2009
 8 S2 p. S51-
1 p.
 artikel
367 Staphylococcus aureus small colony variants (SASCVs) in CF pts treated at Children's Memorial Health Institute, Warsaw, Poland Dmenska, H.
 2009
 8 S2 p. S43-
1 p.
 artikel
368 Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients Filleron, A.
 2009
 8 S2 p. S43-
1 p.
 artikel
369 Strategy for prenatal diagnosis of cystic fibrosis in Russia Petrova, N.V.
 2009
 8 S2 p. S15-
1 p.
 artikel
370 Subsidising exercise in the community: the benefits for adults with cystic fibrosis Gettins, V.J.
 2009
 8 S2 p. S76-
1 p.
 artikel
371 Superiority of ATG induction therapy in lung transplant recipients with cystic fibrosis Jaksch, P.
 2009
 8 S2 p. S68-
1 p.
 artikel
372 Supplement Snack-Bar: a new approach to improve compliance with oral supplements in children with CF Smith, C.
 2009
 8 S2 p. S86-
1 p.
 artikel
373 Survival analysis of CF patients diagnosed in a 35-year neonatal screening program in North-eastern Italy Tacchella, N.
 2009
 8 S2 p. S11-
1 p.
 artikel
374 Synchronisation of intravenous (IV) antibiotic and in vitro susceptibility of sputum Pseudomonas aeruginosa (PA) does not influence outcome of care of adult CF patients–aprospective study Sequeiros, I.
 2009
 8 S2 p. S64-
1 p.
 artikel
375 Synthesis and transfection properties of a series of lipidic neamine derivatives Le Gall, T.
 2009
 8 S2 p. S31-
1 p.
 artikel
376 Target Inhalation Mode, a new Adaptive Aerosol Delivery mode for the reduction of treatment time when using the I-neb AAD System Black, A.
 2009
 8 S2 p. S32-
1 p.
 artikel
377 Telephone calls by CF nurses Panzo, R.
 2009
 8 S2 p. S101-
1 p.
 artikel
378 The Adenovirus chimeric vector Ad5F35/GFP-CFTR efficiently restores the CFTR deficiency in human airway epithelia via apical surface transduction Gonzalez, G.
 2009
 8 S2 p. S30-
1 p.
 artikel
379 The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils Alalwani, S.
 2009
 8 S2 p. S22-
1 p.
 artikel
380 The autopsy reports: Cor pulmonale in CF patients with aging Lee, J.
 2009
 8 S2 p. S60-
1 p.
 artikel
381 The calpain-caspase 12-caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells Kerbiriou, M.
 2009
 8 S2 p. S21-
1 p.
 artikel
382 The CFTRdele2,3 (21 kb) mutation is present in cystic fibrosis patients from Eastern Hungary Balogh, I.
 2009
 8 S2 p. S104-
1 p.
 artikel
383 The Cystic Fibrosis Knowledge Questionnaire (CFKQ) – assessing disease-specific knowledge in adults with CF Nash, E.F.
 2009
 8 S2 p. S111-
1 p.
 artikel
384 The effects of lung transplantation on the nutritional status of patients with cystic fibrosis Caraher, M.
 2009
 8 S2 p. S86-
1 p.
 artikel
385 The experience of using megestrol acetate (MA) in a large UK adult CF centre Barrett, J.
 2009
 8 S2 p. S86-
1 p.
 artikel
386 The extended role of the CF healthcare professional – is it time to re-evaluate our role? MacDougall, L.M.
 2009
 8 S2 p. S101-
1 p.
 artikel
387 The French CF Laboratory Network: seven years' experience Girodon, E.
 2009
 8 S2 p. S2-
1 p.
 artikel
388 The genealogical contribution to the understanding of the diffusion processes of the CFTR mutations: the case study of 1717–1G → A in Brittany (France) Pellen, N.
 2009
 8 S2 p. S105-
1 p.
 artikel
389 The introduction of a new patient ‘welcome pack' Speight, L.
 2009
 8 S2 p. S96-
1 p.
 artikel
390 The “1km challenge” – a novel method to measure changes in exercise tolerance in children with cystic fibrosis during hospital admissions Lester, L.
 2009
 8 S2 p. S71-
1 p.
 artikel
391 The novel long acting ENaC blocker P643 has therapeutic effects in chronic cystic fibrosis-like lung disease in mice Zhou, Z.
 2009
 8 S2 p. S26-
1 p.
 artikel
392 The perceived quality of the cystic fibrosis service and the subjective dimension of the illness experience for patient's parents and caregivers: a survey method to improve the care relationship Grossi, R.
 2009
 8 S2 p. S100-
1 p.
 artikel
393 The role of Magnetic Resonance Imaging (MRI) in predicting severity of disease using a dedicated scoring chest system in patients with cystic fibrosis (CF) Quattrucci, S.
 2009
 8 S2 p. S67-
1 p.
 artikel
394 The significance of Experiential Avoidance concerning anxiety and depression in parents of CF children Smrekar, U.
 2009
 8 S2 p. S90-
1 p.
 artikel
395 The size of the spleen by MRI in patients with CF with and without diabetes Sequeiros, I.
 2009
 8 S2 p. S78-
1 p.
 artikel
396 The spectrum of CFTR mutations in populations from Romania Tamas, L.
 2009
 8 S2 p. S7-
1 p.
 artikel
397 The use of NIV within a regional adult Cystic Fibrosis Centre Barrett, J.
 2009
 8 S2 p. S74-
1 p.
 artikel
398 The Use of Patient Held Drug Information Cards to improve adherence: a questionnaire survey Brady, G.
 2009
 8 S2 p. S93-
1 p.
 artikel
399 The variety of Cystic Fibrosis genotypes of patients from Western Ukraine: ethnographical and population impact Makukh, H.
 2009
 8 S2 p. S7-
1 p.
 artikel
400 Thyroid dysfunction in newly diagnosed cystic fibrosis patients with pancreatic insufficiency and restitution with enzyme therapy Katelari, A.
 2009
 8 S2 p. S83-
1 p.
 artikel
401 TIDES-CF Study: Who participates in psychosocial trials? Bartig, H.J.
 2009
 8 S2 p. S90-
1 p.
 artikel
402 TOBI 300 in Bulgarian cystic fibrosis patients Galeva, I.O.
 2009
 8 S2 p. S65-
1 p.
 artikel
403 Totally Implantable Venous Access devices (TIVADs) in Cystic Fibrosis with particular reference to associated complications Mills, H.L.
 2009
 8 S2 p. S95-
1 p.
 artikel
404 Totally implanted venous access devices (TIVADs) in children with cystic fibrosis: Pilot satisfaction survey Panesar, P.
 2009
 8 S2 p. S93-
1 p.
 artikel
405 To tell or not to tell – Young people's experiences of disclosure Hogan, J.
 2009
 8 S2 p. S99-
1 p.
 artikel
406 Towards a consensus on the early management of infants identified with cystic fibrosis following newborn screening (NBS) Sermet-Gaudelus, I.
 2009
 8 S2 p. S11-
1 p.
 artikel
407 Transition from paediatric to adult: experience of a cystic fibrosis care center Wagner, A.C.
 2009
 8 S2 p. S102-
1 p.
 artikel
408 Treatment of Non-Tuberculous Mycobacteria in Adults with Cystic Fibrosis Haworth, C.S.
 2009
 8 S2 p. S46-
1 p.
 artikel
409 Trisomy 21 – possible cause for false positive sweat test? Pop, L.
 2009
 8 S2 p. S16-
1 p.
 artikel
410 UMD-CFTR: a database dedicated to CF and CFTR-related diseases Bareil, C.
 2009
 8 S2 p. S105-
1 p.
 artikel
411 Use of modified early warning score in adults with Cystic Fibrosis Hughes, T.
 2009
 8 S2 p. S101-
1 p.
 artikel
412 Use of Nintendo Wii for exercise in adult CF patients Boyle, L.
 2009
 8 S2 p. S71-
1 p.
 artikel
413 Validation of an interactive multimedia programme for informed decision-making in cystic fibrosis genetic testing Castellani, C.
 2009
 8 S2 p. S2-
1 p.
 artikel
414 Validation of the MST-25: an extension of the modified shuttle test (MST) Elkins, M.R.
 2009
 8 S2 p. S70-
1 p.
 artikel
415 Variation in bias of self-reported adherence to nebulisers in adults with Cystic Fibrosis Hughes, T.
 2009
 8 S2 p. S92-
1 p.
 artikel
416 Variations on hydrophobic domains in Lipophosphoramidates results in lung transfection's improvement and lower toxicity Montier, T.
 2009
 8 S2 p. S30-
1 p.
 artikel
417 Vascular stenosis in CF patients with totally implantable vascular access devices Greenwood, J.
 2009
 8 S2 p. S95-
1 p.
 artikel
418 Vitamin K deficiency in CF patients is frequent despite its regular supplementation Krzyzanowska, P.
 2009
 8 S2 p. S87-
1 p.
 artikel
419 Vitamin K status and supplementation in children with cystic fibrosis (CF) Jones, K.
 2009
 8 S2 p. S87-
1 p.
 artikel
420 Volatile organic compound analysis in the early detection of Pseudomonas aeruginosa in cystic fibrosis Smith, S.
 2009
 8 S2 p. S36-
1 p.
 artikel
421 Voriconazole therapy in children with cystic fibrosis and steroid-dependant allergic bronchopulmonary aspergillosis: Efficacy and adverse effects Katelari, A.
 2009
 8 S2 p. S57-
1 p.
 artikel
422 Weak anti-inflammatory effects of glucocorticoids on CF bronchial epithelial cells Rebeyrol, C.
 2009
 8 S2 p. S54-
1 p.
 artikel
423 Which quantitative measurement of lung function correlates best with clinical picture during treatment of pulmonary exacerbations in CF? Sequeiros, I.
 2009
 8 S2 p. S62-
1 p.
 artikel
424 Will my CF diet make me ill? Lake, E.
 2009
 8 S2 p. S88-
1 p.
 artikel
425 35-year-old patient with cystic fibrosis (CF) and bilateral pulmonary infiltrates Schwarz, C.
 2009
 8 S2 p. S68-
1 p.
 artikel
426 “You exceeded the cut-off score” – Parental reactions to their HADS-assessments Bartig, H.J.
 2009
 8 S2 p. S90-
1 p.
 artikel
427 Zinc in treatment of children with cystic fibrosis Gorinova, Y.V.
 2009
 8 S2 p. S112-
1 p.
 artikel
                             427 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland